Benefits and drawbacks of moving to biosimilar medicines
Sign Up to like & getrecommendations! Published in 2019 at "Prescriber"
DOI: 10.1002/psb.1773
Abstract: The recent introduction of four biosimilars to the anti‐TNF monoclonal antibody adalimumab has raised the prospect of significant cost savings for the NHS. But what are biosimilar medicines, how easy is it to switch patients… read more here.
Keywords: drawbacks moving; biosimilar medicines; moving biosimilar; benefits drawbacks ... See more keywords